MoneyWorks4Me

Nectar Lifesciences informs about disclosure of related party transactions

07 Jun 2022 Evaluate

Pursuant to Compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended and captioned circular, Nectar Lifesciences has informed that it enclosed the disclosure on Related Party Transactions for half year period from October 01, 2021 to March 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..